Schwabe India Spearheads in Innovation, Research and Development and Signs MoU with RKG Group

Schwabe Group is known for its thoroughly researched natural products. Schwabe India, the Indian subsidiary, has been partnering with different institutes in the country for collaborative researches. In the last few years, the organisation has joined hands with institutes like AIIMS – Bhubaneswar, AIIMS – Rishikesh, Amity University – Noida, Bharati Vidyapeeth University – Pune, DY Patil University – Pune, GB Pant – Delhi, IPGMER – Kolkata, Manipal Hospital – Bangalore, Rajiv Gandhi Institute of Medical Sciences – Andhra Pradesh, Sairam Group – Chennai, Sarada Krishna – Kanniyakumari, Sree Narayana Institute of Medical Sciences – Kerala, Vinayaka Mission’s – Salem, etc. for pre-clinical and clinical studies. Schwabe India’s focussed research areas are dementia,  chemotherapy induced thrombocytopenia, dyspepsia, spondylosis, alopecia, pain management and generalized anxiety disorder. On 26-11-2021, to take forward its ambitions in innovation further, Schwabe India has joined hands with RKG Group, Ghaziabad by signing Memorandum of Understanding. From the RKG Group, Dr. Laxman Prasad – Group Advisor, Dr. Monica Sachdeva – Principal RKGIT (P), Dr. Umesh Kumar – Head of R&D RKGIT(P) and Dr. M. A. Sheela – Associate Professor RKGIT (P) have joined a small event of MoU Ceremony at Schwabe India’s Headquarter in Noida. From Schwabe India, its Managing Director Mr. Ashish Kumar, National Sales Manager Mr. Kamal Pande, Marketing Manager Mr. Dharmender Gautam and Head of Scientific & Medical Affairs Dr. R. Valavan were present. Future works on herbal extracts and formulation developments were discussed.